Dicamba and 2,4-D in the Urine of Pregnant Women in the Midwest: Comparison of Two Cohorts (2010–2012 vs. 2020–2022) Abstract Currently, there are no known human biomonitoring studies that concurrently examine biomarkers of dicamba and 2,4-D. We sought to compare…
As 2022 comes to a close, HHRA is happy to report progress on all fronts. We share some highlights from 2022 and describe what we hope to accomplish in 2023-2025. A NEW MISSION AND VISION As a part of our…
On November 8th, HHRA-sponsored a 90-minute special session on “Herbicides and Birth Outcomes” at the annual meeting of the American Public Health Association (APHA) in Boston. Our session was among a very few exploring how food and farming systems impact…
By: Marlaina Freisthler* Leveraging existing research is central to HHRA’s strategy to accelerate progress in answering contemporary questions about the health impacts of pesticide exposures. One of HHRA’s goals is to draw on existing datasets to glean new insights into…
By: Dr. David M. Haas and Melissa Perry, ScD Over 18% of the babies born in Puerto Rico in 2011 were preterm, increasing life-long risks for multiple adverse developmental, reproductive, and chronic disease outcomes. In that same year, an NIH-funded…
HHRA is pleased to announce a new partnership with the Centre de toxicologie du Québec analytical laboratory, or CTQ. This world-renowned lab will process biological samples collected through HHRA's medical research on the public health implications of pesticide exposure. For…